Old Web
English
Sign In
Acemap
>
authorDetail
>
Alicia Cheong
Alicia Cheong
Celgene
Chemoradiotherapy
Stage III Non-Small Cell Lung Cancer
Pathology
Oncology
Stage III NSCLC
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A New Web-Based Personalized Learning System Improves Student Learning Outcomes.
2022
Int. J. Virtual Pers. Learn. Environ.
Vicente Sancenón
Diaz Adi Utama
Mark Ashworth
Kelvin Hongrui Ng
Alicia Cheong
Show All
Source
Cite
Save
Citations (0)
Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy for newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) in a phase III study (RATIONALE 001).
2019
Journal of Clinical Oncology
Luis Paz-Ares
Suresh Senan
David Planchard
Luhua Wang
Alicia Cheong
Marie Huong Nguyen
Ruta Slepetis
Everett E. Vokes
Show All
Source
Cite
Save
Citations (0)
1